Looks like this is headed lower again. It's amazing how these pre-approval biotech's can be pushed around....It has been a great learning experience. When I started I thought the facts from the lab would be a lot more supportive of the stock price than they actually are. i guess we need actual approvals to realize the appropriate level of share price...Given the way this trades I don't think we should expect any appreciation at ASH with more complete data...This stock will go up when it does and not a moment before...
News 
Market Data 
Discover 
AI
